i-80 Gold Reports Third Quarter 2025 Results and Project Development Progress

CNW/ - i-80 GOLD CORP. (TSX: IAU) (NYSE American: IAUX) ("i-80 Gold" or the "Company") reports its operating and financial ...

Arcutis Canada Announces Health Canada Approval of ZORYVE® Foam 0.3%, the First Steroid-Free Topical Foam for Scalp and Body Psoriasis, for Adults and Adolescents Ages 12 and ...

Arcutis Canada, Inc., a commercial-stage company focused on delivering meaningful innovations in immuno-dermatology, is pleased to announce that Health Canada has approved PrZORYVE® (roflumilast foam ...

Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update

Detailed price information for Spectral Medical Inc (EDT-T) from The Globe and Mail including charting and trades.
Scientific Research Publishing

The Impact of China’s Tax Reform on Per Capita Income: A Regional Analysis Based on Tourism, E-Commerce, and Education Sectors ()

A Regional Analysis Based on Tourism, E-Commerce, and Education Sectors This study assesses the impact of China’s Value-Added Tax (VAT) and Individual Income Tax (IIT) reforms on per capita income ...

Theravance Biopharma, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today reported financial and operational results for the third quarter of 2025.
Unite.AI

AI Can Guess a Photo’s Year From People’s Ages

New research shows AI can use people’s faces to estimate the year a photo was taken, combining age guesses with known birth years to beat current scene-based methods. Guessing the date of a photo used ...
Scientific Research Publishing

Patient Footwear Contamination in Ophthalmic Day Surgery: A Prospective Observational Study ()

Bhangu, J. , Sweetman, S. , Williams, G. and Shuttleworth, G. (2025) Patient Footwear Contamination in Ophthalmic Day Surgery: A Prospective Observational Study. International Journal of Clinical ...

Atea Pharmaceuticals, Inc. (AVIR) Discusses Next-Generation Hepatitis C Treatment Developments and Clinical Advancements Transcript

Atea Pharmaceuticals, Inc. ( AVIR) Discusses Next-Generation Hepatitis C Treatment Developments and Clinical Advancements November 13, 2025 10:00 AM EST Jordan Feld Anthony Martinez Nancy Reau Eric ...